Stock Price Targets and Analyst Ratings

Company	Action	Brokerage	Analyst	Current Price	Price Target	Rating
AAPL Apple	Target Set by	HSBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Erwan Rambourg Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$237.88 -0.8%	$220.00	Hold
AAPL Apple	Target Raised by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Edison Lee Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$237.88 -0.8%	$190.67 ➝ $205.82	Hold
ABM ABM Industries	Reiterated by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew Wittmann Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$46.80 -3.0%	$56.00 ➝ $54.00	Outperform ➝ Neutral
ABM ABM Industries	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joshua Chan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$46.80 -3.0%	$54.00 ➝ $55.00	Buy
ACIU AC Immune	Reiterated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Thomas Shrader Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$2.20 -3.5%	$8.00	Buy
ADBE Adobe	Target Lowered by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gregg Moskowitz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$358.66 +2.8%	$530.00 ➝ $460.00	Outperform
ADBE Adobe	Target Lowered by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Swanson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$358.66 +2.8%	$480.00 ➝ $430.00	Outperform
AFYA Afya	Upgraded by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andre Salles Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$15.61 +3.8%	$19.50 ➝ $19.00	Neutral ➝ Buy
AFYA Afya	Upgraded by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Marcelo Santos Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$15.61 +3.8%	$23.50 ➝ $24.50	Neutral ➝ Overweight
AMX Amex Exploration	Target Raised by	Haywood Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$2.69 +2.7%	C$3.00 ➝ C$4.00
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
ANIP ANI Pharmaceuticals	Target Raised by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vamil Divan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$95.20 -0.2%	$86.00 ➝ $114.00	Buy
AQST Aquestive Therapeutics	Target Raised by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Francois Brisebois Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$5.01 -7.6%	$7.00 ➝ $8.00	Outperform
ARMN Aris Mining	Reiterated by	National Bankshares Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$9.22 +0.4%		Outperform
ASH Ashland	Initiated by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$54.53 -0.7%	$60.00	Equal Weight
ASMB Assembly Biosciences	Target Raised by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vamil Divan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$23.32 -2.1%	$31.00 ➝ $39.00	Buy
ASO Academy Sports and Outdoors	Reiterated by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Heinbockel Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$50.47 -0.8%	$60.00	Buy
AVGO Broadcom	Target Raised by	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jim Kelleher Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$345.65 +3.2%	$285.00 ➝ $375.00	Buy
BA Boeing	Target Set by	Vertical Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Robert Stallard Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$230.89 +0.6%	$242.00 ➝ $270.00	Hold ➝ Buy
BAB Babcock International Group	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 1,104 +1.2%	GBX 1,200	Outperform
BABA Alibaba Group	Reiterated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jiong Shao Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$141.11 +4.1%		Overweight
BBCP Concrete Pumping	Target Raised by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brent Thielman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$7.25 -5.1%	$8.00 ➝ $8.50	Buy
BC Brunswick	Target Raised by	B. Riley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Eric Wold Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$66.80 +0.3%	$60.00 ➝ $70.00	Neutral
BCE BCE	Target Raised by	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$33.67 -1.6%	C$39.50 ➝ C$41.50	Outperform
BKKT Bakkt	Initiated by	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mark Palmer Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$8.95 +5.0%	$13.00	Buy
BLSH Bullish	Initiated by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rayna Kumar Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$50.14 -4.2%		Market Perform
BLSH Bullish	Initiated by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Bedell Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$50.14 -4.2%	$51.00	Hold
BLSH Bullish	Initiated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Peter Christiansen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$50.14 -4.2%	$66.00	Buy
BLSH Bullish	Initiated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brett Knoblauch Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$50.14 -4.2%	$56.00	Overweight
BLSH Bullish	Initiated by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gautam Chhugani Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$50.14 -4.2%	$60.00	Market Perform
BLSH Bullish	Initiated by	Rosenblatt Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Chris Brendler Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$50.14 -4.2%	$60.00	Buy
BLSH Bullish	Initiated by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joseph Vafi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$50.14 -4.2%	$68.00	Buy
BLSH Bullish	Initiated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kenneth Worthington Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$50.14 -4.2%	$50.00	Neutral
BLSH Bullish	Initiated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Daniel Fannon Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$50.14 -4.2%	$49.00	Hold
BMRN BioMarin Pharmaceutical	Initiated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mitchell S. Kapoor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$56.38 -2.4%	$60.00	Neutral
BNTX BioNTech	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Robert Burns Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$102.66 -8.7%	$136.00	Buy
BSX Boston Scientific	Upgraded by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steven Lichtman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$108.14 +0.9%	$118.00 ➝ $125.00	Market Perform ➝ Outperform
BTI British American Tobacco	Upgraded by	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Christine Dooley Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$56.23 +0.4%	$62.00	Hold ➝ Buy
CBRL Cracker Barrel Old Country Store	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jon Tower Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$50.90 -3.6%	$45.00 ➝ $47.00	Sell
CE Celanese	Target Lowered by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Laurence Alexander Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$46.44 -4.7%	$47.00 ➝ $43.00	Hold
CELH Celsius	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Lavery Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$55.64 -4.7%	$60.00 ➝ $69.00	Overweight

CELH Celsius	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bill Chappell Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$55.64 -4.7%	$65.00 ➝ $70.00	Buy
CER Cerillion	Reiterated by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 1,460 +3.5%	GBX 2,350	Buy
CGON CG Oncology	Initiated by	Jones Trading Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Soumit Roy Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$33.69 +1.9%	$50.00	Buy
CGON CG Oncology	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Josh Schimmer Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$33.69 +1.9%	$75.00	Overweight
CHWY Chewy	Upgraded by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Bellinger Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$41.59 -1.7%	$44.00 ➝ $50.00	Neutral ➝ Outperform
CLS Celestica	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Samik Chatterjee Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$244.34 +0.7%	$225.00 ➝ $295.00	Overweight
CLSK Cleanspark	Reiterated by	Chardan Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James McIlree Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$9.17 -0.8%	$20.00	Buy
CLX Clorox	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrea Teixeira Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$125.88 -0.9%	$133.00 ➝ $135.00	Neutral
CMCSA Comcast	Initiated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jonathan Atkin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$34.00 +0.3%	$38.00	Sector Perform
CME CME Group	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Alex Kramm Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$262.58 +0.2%	$305.00 ➝ $285.00	Neutral
COLD Americold Realty Trust	Target Lowered by	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Samir Khanal Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$13.49 -3.5%	$22.00 ➝ $19.00	Outperform
COP ConocoPhillips	Target Lowered by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Freeman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$91.35 -1.7%	$117.00 ➝ $115.00	Outperform
CRCL Circle Internet Group	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Todaro Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$112.41 -1.9%	$250.00	Buy
CRVO CervoMed	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$9.99 -4.9%	$11.00	Neutral
CURV Torrid	Target Lowered by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brooke Roach Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1.66 -7.0%	$2.25 ➝ $1.75	Sell
DKS DICK'S Sporting Goods	Reiterated by	Telsey Advisory Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joseph Feldman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$223.58 +1.1%	$255.00	Outperform
DLTR Dollar Tree	Target Lowered by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Heinbockel Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$99.40 -1.7%	$130.00 ➝ $125.00	Buy
DNLI Denali Therapeutics	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Josh Schimmer Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$15.50 +0.5%		Overweight
DNTH Dianthus Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Swayampakula Ramakanth Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$31.80 +20.0%	$40.00	Buy
DOCU Docusign	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Josh Baer Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$81.73 +2.3%	$86.00 ➝ $90.00	Equal Weight
DOCU Docusign	Reiterated by	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joseph Bonner Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$81.73 +2.3%		Hold
DQ DAQO New Energy	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Air Ma Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$28.02 -4.1%	$27.00 ➝ $37.00	Buy
DRUG Bright Minds Biosciences	Initiated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Thomas Shrader Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$42.97 +1.7%	$72.00	Buy
DUOL Duolingo	Initiated by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Alec Brondolo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$271.28 +0.0%	$239.00	Underweight
DXCM DexCom	Downgraded by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steven Lichtman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$78.00 -3.1%		Outperform ➝ Market Perform
DYAI Dyadic International	Initiated by	Craig Hallum Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$0.97 +6.1%		Buy
ECL Ecolab	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John McNulty Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$275.21 +0.6%	$307.00 ➝ $310.00	Outperform
EE Excelerate Energy	Initiated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$22.95 -3.2%	$30.00	Neutral
ELF e.l.f. Beauty	Reiterated by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Olivia Tong Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$138.15 +3.1%	$140.00 ➝ $155.00	Strong-Buy
EMX EMX Royalty	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Heiko F. Ihle Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$4.29 +5.4%	$5.75	Buy
ENGH Enghouse Systems	Target Lowered by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$20.91 -0.2%	C$26.00 ➝ C$24.00	Sector Perform
ENGH Enghouse Systems	Target Lowered by	CIBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$20.91 -0.2%	C$25.50 ➝ C$25.00	Negative
ENGN enGene	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andres Y. Maldonado Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$5.43 +4.8%	$25.00	Buy
EOLS Evolus	Reiterated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sam Eiber Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$7.61 -0.7%	$18.00	Buy
EWBC East West Bancorp	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Benjamin Gerlinger Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$109.61 +1.9%	$124.00 ➝ $134.00	Buy
EWBC East West Bancorp	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Clark Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$109.61 +1.9%	$100.00 ➝ $104.00	Neutral
FICO Fair Isaac	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kevin Mcveigh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1,540.11 +0.5%	$1,540.00 ➝ $1,590.00	Neutral
FOXA FOX	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steven Cahall Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$62.48 +1.6%	$66.00 ➝ $70.00	Overweight
FR First Industrial Realty Trust	Target Raised by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vikram Malhorta Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$52.21 -0.1%	$53.00 ➝ $56.00	Outperform
FRPT Freshpet	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bryan Adams Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$55.72 +0.8%	$65.00 ➝ $48.00	Sell
GANX Gain Therapeutics	Reiterated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Thomas Shrader Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1.75 -0.6%	$9.00	Buy
GEF Greif	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Roxland Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$61.16 -0.4%	$72.00 ➝ $71.00	Hold
GEI Gibson Energy	Downgraded by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$25.64 -2.5%	C$26.00 ➝ C$27.00	Outperform ➝ Market Perform
GIL Gildan Activewear	Target Raised by	TD Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$77.00 +0.2%	C$60.00 ➝ C$67.00	Buy
GMR Gaming Realms	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 44.60 -11.5%	GBX 57 ➝ GBX 67	Buy
GOOS Canada Goose	Upgraded by	TD Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$20.85 +12.4%	C$22.00 ➝ C$25.00	Hold ➝ Buy
GOOS Canada Goose	Upgraded by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Oliver Chen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$15.08 +12.6%	$16.00 ➝ $18.00	Hold ➝ Buy
GT Goodyear Tire & Rubber	Initiated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ross MacDonald Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$8.59 +1.1%	$10.00	Neutral
GWRE Guidewire Software	Target Raised by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Peter Heckmann Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$261.90 +0.5%	$246.00 ➝ $250.00	Neutral
HBM HudBay Minerals	Initiated by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$13.22 +3.9%		Buy

HLI Houlihan Lokey	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ryan Kenny Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$198.65 +0.8%	$192.00 ➝ $213.00	Overweight
HWC Hancock Whitney	Target Raised by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Rose Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$62.90 +0.3%	$68.00 ➝ $73.00	Strong-Buy
IBRX ImmunityBio	Reiterated by	D. Boral Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jason Kolbert Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$2.41 +0.4%	$24.00	Buy
IFF International Flavors & Fragrances	Upgraded by	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Chris Parkinson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$66.22 +0.3%		Underperform ➝ Peer Perform
IMAB I-Mab	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gil Blum Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$4.27 -2.5%	$6.00	Buy
INSM Insmed	Target Raised by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vamil Divan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$146.68 +1.1%	$125.00 ➝ $172.00	Buy
IOT Samsara	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Keith Weiss Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$41.43 -1.6%	$50.00 ➝ $53.00	Equal Weight
IPO InPlay Oil	Target Set by	National Bankshares Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$11.83 +4.0%	C$16.00	Outperform
IPOOF INPLAY OIL CP	Initiated by	National Bankshares Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$8.50 +3.3%		Outperform
JBGS JBG SMITH Properties	Target Lowered by	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steve Sakwa Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$23.01 +1.2%	$20.00 ➝ $19.00	Underperform
JBLU JetBlue Airways	Target Raised by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$5.18 +2.0%	$4.00 ➝ $5.00	Hold
JEF Jefferies Financial Group	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ryan Kenny Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$64.18 +1.1%	$54.00 ➝ $72.00	Equal Weight
KALA KALA BIO	Initiated by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Graig Suvannavejh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$14.48 -0.5%	$30.00	Outperform
KIM Kimco Realty	Target Raised by	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steve Sakwa Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$22.53 -1.0%	$22.00 ➝ $23.00	In-Line
KNTK Kinetik	Target Lowered by	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brandon Bingham Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$41.58 -0.9%	$55.00 ➝ $53.00	Sector Outperform
KNTK Kinetik	Reiterated by	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brandon Bingham Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$41.58 -0.9%		Outperform
KRC Kilroy Realty	Target Raised by	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steve Sakwa Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$42.71 +0.0%	$42.00 ➝ $46.00	In-Line
KVUE Kenvue	Target Lowered by	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Javier Escalante Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$18.44 -1.0%	$25.00 ➝ $23.00	In-Line
LAZ Lazard	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ryan Kenny Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$56.19 -0.4%	$47.00 ➝ $61.00	Underweight
LIDR AEye	Initiated by	Alliance Global Partners Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	C.K. Poe Fratt Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$2.88 +2.5%	$6.00	Buy
LINE Lineage	Target Lowered by	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steve Sakwa Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$39.97 -1.5%	$50.00 ➝ $43.00	In-Line
LRCX Lam Research	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Atif Malik Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$105.07 +2.1%	$113.00 ➝ $120.00	Buy
LUNG Pulmonx	Reiterated by	D. Boral Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jason Kolbert Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1.70 -2.3%	$16.00	Buy
LZ LegalZoom.com	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ella Smith Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$10.35 +0.3%	$12.00 ➝ $14.00	Overweight
MBUU Malibu Boats	Target Lowered by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Griffin Bryan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$33.03 -1.9%	$33.00 ➝ $31.00	Neutral
MC Moelis & Company	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ryan Kenny Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$72.44 +2.5%	$74.00 ➝ $90.00	Overweight
MIAX Miami International	Initiated by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$37.35 +6.9%		Market Perform
MIAX Miami International	Initiated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kenneth Worthington Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$37.35 +6.9%	$32.00	Neutral
MIAX Miami International	Initiated by	William Blair Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jeff Schmitt Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$37.35 +6.9%		Outperform
MIAX Miami International	Initiated by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Moley Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$37.35 +6.9%	$39.00	Overweight
MIAX Miami International	Initiated by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Cyprys Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$37.35 +6.9%	$42.00	Overweight
MIAX Miami International	Initiated by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kyle Voigt Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$37.35 +6.9%	$37.00	Market Perform
MIAX Miami International	Initiated by	Rosenblatt Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Chris Brendler Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$37.35 +6.9%	$50.00	Buy
MKS Marks and Spencer Group	Upgraded by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 352.10 +3.4%	GBX 380 ➝ GBX 440	Buy
MLYS Mineralys Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Caufield Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$35.93 +3.2%	$42.00	Buy
MRO Melrose Industries	Target Raised by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 613.07 -0.3%	GBX 585 ➝ GBX 620	Hold
MZDAY Mazda Motor	Upgraded by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$3.95 +6.0%		Neutral ➝ Buy
NFE New Fortress Energy	Reiterated by	Capital One Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$1.40 -42.9%		Equal Weight ➝ Underweight
NRXP NRx Pharmaceuticals	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick R. Trucchio Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$2.84 +3.3%	$40.00	Buy
NRXP NRx Pharmaceuticals	Reiterated by	D. Boral Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jason Kolbert Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$2.84 +3.3%	$34.00	Buy
NUVB Nuvation Bio	Reiterated by	Wedbush Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Nierengarten Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$3.48 -10.9%	$6.00	Outperform
NUVL Nuvalent	Reiterated by	Wedbush Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Nierengarten Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$79.83 -1.3%	$115.00	Outperform
NVDA NVIDIA	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Atif Malik Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$168.31 +0.8%	$210.00 ➝ $200.00	Buy
OGC OceanaGold	Upgraded by	TD Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$27.32 +2.5%	C$22.00 ➝ C$30.00	Hold ➝ Buy
ONT Oxford Nanopore Technologies	Target Raised by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 170.08 +4.9%	GBX 250 ➝ GBX 280	Outperform
ORCL Oracle	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Raimo Lenschow Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$238.78 +2.6%	$221.00 ➝ $281.00	Overweight
ORCL Oracle	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mark Murphy Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$238.78 +2.6%	$185.00 ➝ $210.00	Neutral
ORCL Oracle	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Keith Weiss Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$238.78 +2.6%	$175.00 ➝ $246.00	Equal Weight
PAA Plains All American Pipeline	Reiterated by	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brandon Bingham Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$17.16 -0.3%		Outperform
PAA Plains All American Pipeline	Target Raised by	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brandon Bingham Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$17.16 -0.3%	$18.00 ➝ $20.00	Sector Outperform

PANR Pantheon Resources	Reiterated by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 32 +10.7%	GBX 70	Speculative Buy
PATH UiPath	Target Lowered by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kingsley Crane Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$11.80 +2.7%	$16.00 ➝ $15.00	Buy
PHR Phreesia	Target Raised by	JMP Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Silvan Tuerkcan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$26.78 -4.8%	$30.00 ➝ $34.00	Market Outperform
PII Polaris	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Robin Farley Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$59.51 +0.6%	$45.00 ➝ $58.00	Neutral
PODD Insulet	Target Raised by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steven Lichtman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$349.56 +0.3%	$324.00 ➝ $365.00	Outperform
PSNL Personalis	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Swayampakula Ramakanth Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$5.32 +1.5%	$8.50	Buy
QBR.A Quebecor	Target Raised by	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$43.92 +0.7%	C$40.50 ➝ C$43.25	Sector Perform
QURE uniQure	Reiterated by	Chardan Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Daniil Gataulin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$17.43 -2.9%	$35.00	Buy
RAPP Rapport Therapeutics	Target Raised by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Douglas Tsao Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$31.47 +119.2%	$31.00 ➝ $34.00	Buy
RBLX Roblox	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Omar Dessouky Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$128.56 +0.7%	$159.00 ➝ $171.00	Buy
RCI.B Rogers Communications	Target Raised by	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$49.36 -0.7%	C$51.50 ➝ C$54.26	Sector Perform
REPL Replimune Group	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Robert Burns Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$6.04 -4.6%		Neutral
REXR Rexford Industrial Realty	Target Raised by	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Samir Khanal Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$42.92 +0.1%	$38.00 ➝ $39.00	In-Line
REXR Rexford Industrial Realty	Target Raised by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vikram Malhotra Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$42.92 +0.1%	$37.00 ➝ $40.00	Neutral
RGNX REGENXBIO	Reiterated by	Chardan Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Daniil Gataulin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$9.48 -2.4%	$52.00	Buy
RGNX REGENXBIO	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Yi Chen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$9.48 -2.4%	$34.00	Buy
RH RH	Reiterated by	Telsey Advisory Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Cristina Fernandez Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$240.38 -4.2%	$255.00	Outperform
RH RH	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Zachary Fadem Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$240.38 -4.2%	$275.00 ➝ $295.00	Overweight
RL Ralph Lauren	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ike Boruchow Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$308.52 -1.1%	$320.00 ➝ $345.00	Overweight
ROKU Roku	Target Raised by	JMP Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Condon Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$99.39 +4.4%	$110.00 ➝ $145.00	Market Outperform
RSI Rush Street Interactive	Target Raised by	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mike Hickey Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$20.97 -1.0%	$20.00 ➝ $24.00	Buy
RYAAY Ryanair	Downgraded by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$59.81 -1.2%		Buy ➝ Neutral
SAIC Science Applications International	Reiterated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Seth Seifman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$102.60 -2.2%	$140.00 ➝ $115.00	Overweight ➝ Neutral
SAIC Science Applications International	Target Lowered by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gavin Parsons Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$102.60 -2.2%	$104.00 ➝ $91.00	Sell
SHLS Shoals Technologies Group	Target Raised by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Julien Dumoulin-Smith Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$7.14 -0.3%	$6.00 ➝ $9.00	Buy
SION Sionna Therapeutics	Initiated by	Jones Trading Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Debanjana Chatterjee Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$21.62 -9.9%	$46.00	Buy
SKWD Skyward Specialty Insurance Group	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Zaremski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$50.23	$52.00 ➝ $55.00	Market Perform
SLI Standard Lithium	Reiterated by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$2.95 -3.9%		Outperform
SMMT Summit Therapeutics	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Eric Schmidt Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$19.44 -25.2%		Overweight
SMMT Summit Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mitchell S. Kapoor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$19.44 -25.2%	$50.00	Buy
SNY Sanofi	Upgraded by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mark Purcell Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$46.80 +0.6%	$56.00 ➝ $58.00	Equal Weight ➝ Overweight
SPWR CSLM Acquisition	Initiated by	Northland Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$1.50	$3.00	Outperform
STLA Stellantis	Initiated by	BNP Paribas Exane Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$8.95 -1.5%	$10.10	Neutral
STNG Scorpio Tankers	Upgraded by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ken Hoexter Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$58.62 +10.5%	$49.00 ➝ $60.00	Neutral ➝ Buy
STNG Scorpio Tankers	Target Raised by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Omar Nokta Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$58.62 +10.5%	$65.00 ➝ $70.00	Buy
STTK Shattuck Labs	Initiated by	Wedbush Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Nierengarten Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1.88 +21.3%	$4.00	Outperform
STX Seagate Technology	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Asiya Merchant Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$189.24 +0.6%	$167.00 ➝ $215.00	Buy
SVRA Savara	Target Raised by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andreas Argyrides Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$3.85 +3.5%	$6.00 ➝ $8.00	Outperform
T TELUS	Target Raised by	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$22.70 -1.2%	C$25.00 ➝ C$26.00	Outperform
TCL.A Transcontinental	Target Lowered by	Cormark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$20.59 +1.1%	C$27.00 ➝ C$26.00
TCL.A Transcontinental	Target Raised by	TD Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$20.59 +1.1%	C$26.00 ➝ C$27.00	Buy
TDG Transdigm Group	Downgraded by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ken Herbert Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1,292.99 +1.7%	$1,550.00 ➝ $1,385.00	Outperform ➝ Sector Perform
TECK Teck Resources	Upgraded by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Abhi Agarwal Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$35.17 +2.5%	$42.00	Hold ➝ Buy
TECK.B Teck Resources	Target Lowered by	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$48.50 +2.0%	C$57.00 ➝ C$55.00	Outperform
TENX Tenax Therapeutics	Initiated by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Yasmeen Rahimi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$6.04 +0.8%	$20.00	Overweight
TEO Telecom Argentina Stet - France Telecom	Upgraded by	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andres Coello Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$7.16 -16.0%	$4.50 ➝ $8.20	Sector Underperform ➝ Sector Perform
TNDM Tandem Diabetes Care	Initiated by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steven Lichtman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$12.50 -0.6%	$44.00 ➝ $22.00	Outperform
TSEM Tower Semiconductor	Target Raised by	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Cody Acree Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$64.85 +2.6%	$66.00 ➝ $73.00	Buy
TTD Trade Desk	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Laura Martin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$52.03 -0.1%	$84.00	Buy
TXN Texas Instruments	Reiterated by	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Cody Acree Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$185.82 -1.1%	$220.00	Buy

ULTA Ulta Beauty	Reiterated by	Telsey Advisory Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Dana Telsey Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$519.81 +1.0%	$610.00	Outperform
UMBF UMB Financial	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Foran Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$125.59 +0.9%	$130.00 ➝ $144.00	Buy
USCB USCB Financial	Upgraded by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Rose Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$17.25 -1.0%	$20.00 ➝ $22.00	Outperform ➝ Strong-Buy
USCB USCB Financial	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Stephen Scouten Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$17.25 -1.0%	$22.00 ➝ $23.00	Overweight
VALN Valneva	Target Lowered by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vamil Divan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$8.52 -1.5%	$14.00 ➝ $13.00	Buy
VEEV Veeva Systems	Upgraded by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Alexei Gogolev Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$282.97 +3.7%	$290.00 ➝ $330.00	Neutral ➝ Overweight
VLVLY AB Volvo	Downgraded by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$29.18 -1.1%		Buy ➝ Neutral
VVV Valvoline	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Peter Keith Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$39.93 +2.3%	$44.00 ➝ $50.00	Overweight
WDC Western Digital	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Asiya Merchant Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$93.29 +1.4%	$88.00 ➝ $110.00	Buy
WPM Wheaton Precious Metals	Target Raised by	Peel Hunt Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$146.46 +1.4%	C$149.00 ➝ C$161.00	Buy

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 07:15 PM ET.

Stock Ratings and Recommendations: Understanding Analyst Ratings

Written by MarketBeat Staff

July 5, 2023

Key Points

Stock analysts give ratings to companies based on their research and insights.
Analysis comes from the buy side (fund companies, investment managers) or sell side (brokers, banks).
Analysts use different methodologies, so investors should always look into why a particular rating was given.
5 stocks we like better than EXA)

You'll often hear a particular stock called a "buy" or "sell," but who exactly makes these calls? Ratings and recommendations come from stock analysts, who research different securities and work for various institutions, brokerage firms and other financial companies.

Analyst ratings are designed to give additional information to investors beyond just what the company is saying, but are analyst ratings reliable? In this article, we'll discuss how to read analyst ratings, what goes into their decision-making process and how potential conflicts of interest influence analyst stock ratings.

What Are Analyst Ratings?

A stock rating is a simple heuristic given by analysts who review the firm's financial statements, listen to conference calls, chat with company executives and compare the stock to others in the industry or sector. Finally, an analyst uses all this information to produce a simple recommendation and price target.

When a public analyst goes on CNBC or the "Wall Street Journal" to give a "buy" or "sell" rating on a particular stock, they take all their research and pare it down into a simple designation. While there's no true consensus on what constitutes a buy or sell rating, an analyst usually does have "skin in the game" when devising ratings.

Ratings often pair with price targets, which put a hard number on what the analysts believe the company stock should be worth. So, for example, you might see an analyst report something like, "Buy NVIDIA Inc. (NASDAQ: NVDA), price target $350," which means that particular analyst believes investors should buy NVDA shares up to a price of $350 per share.

Analyst ratings infographic: What you need to know

What Does a Stock Analyst Do?

A stock analyst is a market professional with the skills to interpret financial data and the connections within companies to speak on the record with higher-ups. Analysts generally fall into one of two different camps: buy-side or sell-side. These positions will seem similar, but they tend to be employed by various institutions and have different responsibilities in their particular market "territories."

Buy-side analysts: Analysts on the buy side tend to work for funds, such as ETF providers or hedge funds. They don't dig as deeply into company financial data or conference calls as sell-siders. Instead, they focus on general areas or industries where their funds have vested interests. In addition, buy-side analysts often forge relationships with sell-side analysts for individual stock research. A buy-side analyst's primary goal is to find and utilize the most accurate and dependable sell-side analysts.
Sell-side analysts: If buy-side analysts work for funds (i.e., institutions that buy securities), you can probably guess which type of institution employs sell-side analysts. Brokers, banks and other firms that sell securities to investors use sell-side analysts to give reports to the public. While buy-side analysts also give ratings and price targets, the reported "buy" and "sell" ratings in financial media typically come from folks on the sell side.

Buy and sell-side analysts often use different rating systems when making their recommendations. You might even find two sell-side analysts with similar "buy" recommendations with vastly different price targets in the same stock. As a result, you'll need to familiarize yourself with the various methodologies analysts use to utilize their research correctly.

What Ratings Do Analysts Give?

Stock analyst ratings don't follow a strict structure, although most have roughly the same grading system for the securities they review. The labels may differ slightly (i.e., overweight vs. outperform), but the five most common analyst ratings go like this.

Buy

Analysts bullish on a particular security will give it a "buy" rating and set a price target above the current market price. In addition, if the analyst considers the stock one of the best in the industry or sector, you'll sometimes see a "strong buy" rating attached.

Hold

A "hold" rating is typically the lowest rating a sell-side analyst gives a stock. "Hold" means the analyst projects the stock to meet the return of the market averages, making it an unspectacular investment. Stocks rated "hold" may still have a price target above the current price, but it's not likely to surpass the return of a major index like the S&P 500.

Sell

Analysts are usually apprehensive about giving a stock a "sell" rating. For example, suppose a "hold" rating indicates indecision over the stock's future. In this scenario, a "sell" rating is issued when an analyst finds something unappealing, such as questionable accounting tactics or cratering sales growth.

Underperform

Analysts won't always give a firm "buy" or "sell" rating on stock but will instead label it "underperform" or "outperform." "Underperform" means the analyst expects the stock not to keep up with the market. It doesn't necessarily mean the analyst predicts a crash but indicates a lack of confidence in the shares.

Outperform

"Outperform" is the opposite of "underperform," meaning the analyst expects the stock to do better than the market average. It's usually considered a less confident rating than "buy."

Example of an Analyst Rating

You can use MarketBeat Analyst Ratings to find ranges and aggregates from buy- and sell-side analysts across the financial media. For example, here's a stock that analysts usually love: Alphabet Inc. (NASDAQ: GOOG).

Overview of stock analysis on GOOG Using MarketBeat's tools, you can find ratings from prominent analysts from multiple periods. Alphabet is currently labeled a "moderate buy" based on MarketBeat's consensus from 17 analysts. You'll get the consensus price target and the highest and lowest from the analysts surveyed.

Marketbeat's tools detailing analyst ratings

Looking at analyst recommendations over time is another helpful tool. For example, you can view the different levels of coverage over the last few years, which analysts changed their ratings and how the price targets vary from month to month. If an analyst can't get a good read on a particular stock they've been covering, they might choose to withhold their grade, which is one reason why the number of available ratings can change over time.

Overview of analyst ratings on MarketBeat Analysts from both sides of the aisle can be found on MarketBeat, ranging from large firms like JPMorgan Chase and Co. (NYSE: JPM) to smaller investment banks like Roth Capital. Some institutions like UBS Group offer both buy-side and sell-side ratings and analysis. These graphs show that even analysts with similar ratings can have vastly different price targets, so always understand the reasoning behind an analyst's view.

How to Use Analyst Ratings

Here are a few pointers on incorporating analyst ratings into your investment research.

Step 1: Don't rely on a single analyst.

Using an array of analysts (buy- and sell-side) gives inventors the most possible information. Don't just look for analysts with similar opinions as yourself — ensure you understand the pros and cons of each investment you make by incorporating positive and negative views, if possible.

Step 2: Compare analyst ratings across the industry or sector.

It's easy to slap a "buy" rating on a stock and predict a winner, but comparing stocks against others in the sector can offer insight into the rating. For example, if a stock is rated "buy" in the information technology sector, but a dozen others are rated "strong buy" by the same analyst, where is your capital best served?

Step 3: Consider your own goals and risk tolerance.

You might find stocks rated "strong buy" in your research in sectors you wish to avoid. That's fine! There are thousands of securities across dozens of industries in the public markets, and you don't need to purchase every share that comes with a "buy" rating. Instead, stick to your investment plan.

Step 4: Don't stubbornly stick to your original assessments.

Following your investment plan and using analyst ratings as guidelines are practical steps, but things can change over time. Today's "strong buy" stocks could be "strong sell" stocks down the road. Using an aggregate of analysts' ratings can help investors view stocks from a higher level. For example, if the number of "buy" ratings on a stock drops 40% over a few years, you might want to take a closer look at that particular company.

Why Are Analyst Ratings Important?

Checking out analyst ratings isn't a necessary step for investing, but it can be helpful for those looking to dig deep into an asset's prospects. Analyst research often has quotes from company executives, questions from conference calls and in-depth reporting on the company's balance sheet, income statement and other essential documents. Analysis like this is complex for individual investors to do on their own, especially considering how frequently analysts interact with the executives they cover. But access often comes with a downside, which we discuss more below.

How Accurate Are Analyst Ratings?

Both buy and sell-side analysts strive for accuracy because giving consistently wrong commendations can be hazardous for job security. However, investors should be aware that analysts might not always have the best interest of the retail investor at heart when making their recommendations.

For starters, being an analyst requires access to company employees and management. Analysts typically ask questions during conference calls and speak with C-suite executives on the record about their firms' prospects. Executives usually don't want to hear adverse reports about their companies, so analysts are incentivized to paint a rosy picture to retain access. The SEC has been questioning the authenticity of analyst ratings (especially on the sell-side) since 2002 when it asked bluntly, "Why are there so few sell ratings?"

Of course, there are other areas of the securities analysis market to face scrutiny. If you recall, during the 2008 financial crisis, the biggest credit rating agencies were all held to the fire due to claims that conflicts of interest influenced their ratings. The biggest rating agencies in the world were accused of "misrepresenting the risks associated with mortgage-backed securities." Remember, analyst ratings aren't spat out by computer algorithms but by living, breathing people who may have agendas other than providing the most precise and accurate reports on a company's future prospects.

Analyst Ratings Can Guide Investors, but Don't Treat Them as Gospel

Consider each type of investment research or advice in collaboration. Even the most accurate and thoughtful analysts get things wrong, plus ratings are frequently besieged with conflicts of interest. But analyst coverage does offer research that's difficult to get elsewhere, and using an array of analyst reports can give investors a deeper understanding of the securities they buy.

FAQs

Still have questions about analyst ratings? Here are a few answers to some common points of discussion:

What are analyst ratings?

Analyst ratings are the "buy" and "sell" labels, plus price targets, that investment researchers attach to specific securities. These ratings are based on financial data, earnings reports and conversations with company executives.

Should you trust analyst ratings?

Analyst ratings provide plenty of helpful information, but you shouldn't use an analyst's "buy" rating as the sole reason you purchase a security. Analysts aren't immune to conflicts of interest or outside parties' influence, so ensure you always understand why a stock was labeled a "buy" or "sell."

What does an analyst rating tell you about a stock?

Ratings give investors the analyst's overall opinion about a particular stock and price targets based on the company's valuation and prospects. Analysts often attend conference calls, ask questions and provide in-depth information about companies that are difficult to acquire elsewhere.

Stock Forecasts and Research Tools

Today's Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Stock Price Targets and Analyst Ratings